Weekly Trading Update
26.08.16 Friday Morning
UK
This week starts with a bank holiday in the UK and information is at a premium for the first half of the week. The year on year and month on month House Price Index released on Wednesday is the only update of note. However, traders will be interested in the Purchasing Managers’ Index for manufacturing (Thursday) and construction (Friday). Both values are expected to be slightly higher than July’s readings. The FTSE has retreated slightly since the highs of two weeks ago and it will be interesting to see how these figures affect this.
US
The week may also be slow to get going in the States with the first stat of note coming in the form of Tuesday’s Consumer Confidence rating. However, this is predicted to be relatively unmoved from the 97.3 level for July and so is unlikely to cause any shift in the markets. Wednesday appears to be the pivotal day of the week with three major pieces of data to be released. Nonfarm Employment change is thought to be 170,000, slowing from last month’s 179,000 increase. Pending Home Sales month on month is predicted to rise to 0.7% from 0.2%; and Crude Oil Inventories are reported. This shows the weekly change in the number of barrels of commercial crude oil held by US firms and so has a big impact on the price of oil. Thursday sees the release of the US’ manufacturing PMI and the week ends with a report on Nonfarm Payrolls. This figure is expected to drop to 180,000, down from 255,000 from the previous month.
Eurozone
The information vacuum continues in Europe to start the week with traders having to wait until Wednesday again for the first point of interest. German Unemployment Change looks to be particularly interesting, forecasted to move from -7,000 to -4,000. This is followed by a year on year CPI for the whole of the Eurozone, although this figure is not expected to have much of an effect on the markets. We again see a manufacturing PMI on Thursday, this time from Germany, but there is likely to be little change here either.
Stock of the week: Mylan PLC
The healthcare company came under fire over their $600 price tag on its EpiPen. Mylan CEO, Heather Bresch, held “the middlemen” responsible although, Express Scripts chief medical officer, Steve Miller, was not convinced; stating “If she wants to lower the price she can lower the price today”. The issue has caused something of a furore in the Pharmaceutical industry and so it will be interesting to watch how this develops in the coming week.
Open (Monday)
6835.78
Close (Thursday)
6826.9
Change
-0.27%
High
6836.22
Low
6779.15
Open (Monday)
18471.21
Close (Thursday)
18448.41
Change
-0.12%
High
18497.68
Low
18431.46
Open (Monday)
1321.4
Close (Thursday)
1320.1
Change
-0.09%
High
1324
Low
1317
Open (Monday)
1.3231
Close (Thursday)
1.3191
Change
-0.30%
High
1.3264
Low
1.3164
It's easy to open an account
- Fill in our simple online application form
- Fund your account
- Start trading the global markets instantly!
SEARCH FOR AN ARTICLE:
Enter a keyword and search for all relevant articlesMARKET ANALYSIS
RECENT POSTS
DISCLAIMER
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.
Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.
No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.
The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.